ClearPoint Neuro (CLPT) Raw Materials (2024 - 2026)

ClearPoint Neuro (CLPT) posted Raw Materials of $6.7 million for Q1 2026, down 4.68% sequentially from $7.1 million in Q4 2025.

ClearPoint Neuro (CLPT) Raw Materials (2024 - 2026) Analysis & Trends

ClearPoint Neuro has reported Raw Materials for 3 years, with the latest figure at $6.7 million in Q1 2026.

Quarterly Raw Materials changed N/A year-over-year to $6.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.7 million (changed N/A YoY) and the FY2025 annual result came in at $7.1 million, up 28.15% from the prior year.
Raw Materials fell to $6.7 million in Q1 2026 per CLPT's latest filing, from $7.1 million in the prior quarter.
Over five years, Raw Materials peaked at $7.1 million in Q4 2025 and troughed at $5.5 million in Q4 2024.
A 3-year average of $6.2 million and a median of $6.1 million in 2025 frame the typical range for Raw Materials.
The widest YoY moves for Raw Materials: up 28.15% in 2025, down 28.15% in 2025.
Over 3 years, Raw Materials stood at $5.5 million in 2024, then advanced by 28.15% to $7.1 million in 2025, then slipped by 4.68% to $6.7 million in 2026.
According to Business Quant data, Raw Materials over the past three periods registered $6.7 million, $7.1 million, and $6.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	199.12 Bn	193.52 Bn	7.27 Bn
2	Stryker	128.79 Bn	125.32 Bn	4.50 Bn
3	Medtronic	119.30 Bn	110.08 Bn	6.41 Bn
4	Boston Scientific	73.50 Bn	72.96 Bn	3.85 Bn
5	Edwards Lifesciences	52.11 Bn	47.86 Bn	1.35 Bn
6	Dexcom	34.62 Bn	32.67 Bn	830.00 Mn
7	GE HealthCare Technologies	34.05 Bn	31.94 Bn	2.18 Bn
8	Koninklijke Philips	26.42 Bn	23.10 Bn	4.55 Bn
9	Steris	23.15 Bn	22.67 Bn	684.20 Mn
10	ClearPoint Neuro	468.49 Mn	439.09 Mn	6.71 Mn

Download Data